PepEvolutionSemaglutide Dosage: What the Label and Trials Show
Semaglutide · Ozempic / Wegovy
Status & framing. Semaglutide is FDA-approved as Ozempic (type 2 diabetes) and Wegovy (chronic weight management) in branded pens. Research/compounded vials are not the approved products. Figures below cite labeled titration and trial context, not a recommendation to use non-approved products.
What the research shows
Approved pen products use once-weekly subcutaneous titration. Wegovy starts at 0.25 mg weekly for 4 weeks, then steps up toward a 2.4 mg maintenance dose when tolerated. Ozempic uses a related weekly titration path for glycemic control. Human evidence is extensive for the approved products; research vials are a different supply channel.
Doses used in studies
Each row is a dose as reported in the cited source, not a recommendation. Superscripts link to sources below.
| Context | Dose studied | Route / frequency |
|---|---|---|
| Wegovy label, titration start | 0.25 mg once weekly for 4 weeks[1]⚠ Approved product dose path. Compounded/research vials are not Wegovy. | Subcutaneous (approved pen) |
| Wegovy label, maintenance target | 2.4 mg once weekly (when tolerated)[1] | Subcutaneous (approved pen) |
| STEP / obesity trial context | Weekly titration toward 2.4 mg[2]⚠ Trial product and medical supervision context. | Subcutaneous |
Reconstitution & example math
A 5 mg research vial reconstituted with 2 mL bacteriostatic water yields 2.5 mg/mL. A 0.25 mg (250 mcg) example draw is 0.1 mL, or 10 units on a U-100 syringe. That is an arithmetic example only, not a protocol.
Approved products are pens with fixed dosing. Research vials require independent concentration math and cold-chain handling. Do not treat vial math as a substitute for labeled therapy.
Route, half-life & timing
Safety & side-effect notes from the literature
- Approved labels carry GI adverse effects, boxed/warning language around thyroid C-cell tumor risk in rodents, and multiple contraindications. Read the current label.[1]
- Compounded or research-channel products are not the FDA-approved pens and may differ in salt form, impurities, and dosing accuracy.[3]
Frequently asked
What is the starting dose of Wegovy semaglutide?+
The Wegovy label starts at 0.25 mg once weekly for 4 weeks, then titrates upward when tolerated toward a 2.4 mg weekly maintenance dose.
Are research vials the same as Ozempic or Wegovy?+
No. Ozempic and Wegovy are specific approved pen products. Research or compounded vials are a different channel and are not those approved products.
Get the full Semaglutide protocol
PepEvolution Pro turns these research ranges into a personalized schedule, a full Semaglutide protocol with a week-by-week plan, sourcing shortlist, and COA-checked vendors. Educational, cited, and built on the same methodology.
See what's in Pro →Email me the Semaglutide protocol
Get this Semaglutide dosing summary plus related reconstitution and sourcing guides. Research/educational only.
Sources & Citations
Primary sources only. Doses are stated as reported, see methodology.
Related
Educational only, not medical advice. Doses on this page are figures used in published research or clinical labeling, presented for education. They are not a prescription or a recommendation to self-administer. Consult a licensed healthcare provider before using any compound.